Treatment Horizons

On July 26, 2017, the Centers for Disease Control and Prevention released new data on the nation’s progress in HIV testing and treatment, showing...

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Countdown Researcher Jia Xie discusses a cutting-edge treatment in development by Dann Dulin Block HIV by using the body’s own immune cells? Is it truly possible?! Well, such...

LifeGuide Treatment Horizons The Road Ahead New candidates hold promise for ARV therapy & therapeutic vaccines by Mariel Selbovitz, MPH The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...

Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients by Chael Needle Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...

HIVHealthReform.org offers chances to learn about & advocate for new policies by Chael Needle The Patient Protection and Affordable Care Act, created by the Obama administration,...

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

LifeGuide Based in San Diego, a prevention model aims to reach everyone Everybody should be tested for HIV. That message is the basis for Lead...

On November 21, 2017, the U.S. Food and Drug Administration (FDA) approved the first-ever two-drug once-daily single-pill regimen for the maintenance treatment of adults...